Active tuberculosis treatment in former times--nostalgic reminiscences of an exciting therapy era
Reimers, D.
Praxis und Klinik der Pneumologie 39(11): 447-456
1985
ISSN/ISBN: 0342-7498 PMID: 3909137 Document Number: 242769
Document emailed within 1 workday
Related Documents
Ashcroft, F.M. 1998: Exciting times for PIP2 Science 282(5391): 1059-1060Bonar, S. 2010: Exciting political times ahead Midwives 2010: 25
Tacke, U.; Ebert, M.H. 1988: Excitotoxins and the NMDA-receptor exciting times for neuroscience research Nordisk Medicin 103(6-7): 192-193; 197
Åkerlund, A.; Sundqvist, M.; Hanberger, H.åk.; Åhrén, C.; Serrander, L.; Giske, C.G. 2015: Response times can be shortened in microbiological diagnosis of sepsis. Better opening hours in laboratories and active advice enables faster therapy Lakartidningen 112
Forschbach, G. 1988: Active therapy of lung tuberculosis in the pre-chemotherapy era Praxis und Klinik der Pneumologie 42(12): 878-882
Sergeev, I.S.; Gur'eva, I.G.; Starostenko, E.V.; Ignatova, A.V.; Fedotova, Z.N. 1972: Proportional content of 11-oxycorticosteroids and indications for hormonal therapy in patients with active pulmonary tuberculosis Problemy Tuberkuleza 50(7): 12-16
Sales, A.C.d.S.; Lopes, L.A.új.; Vale, M.C.D.S.; Costa, M.F.; Lima, J.ão.V.d.S.; Silva, J.ão.G.M.d.; Ferreira, B.S.d.C.; Nascimento, V.A.d.; Flor, S.E.d.S.; Sousa, E.L.C.d.; Paz, B.K.B.; Garcia, R.A.d.S.; Sousa, E.M.d.; Santos, A.F.D.; Silva, L.ís.C.áu.N.d.; Zagmignan, A. 2023: Clinical Features, Biochemical Parameters, and Treatment Adherence of Individuals who Started the Treatment for Active Pulmonary Tuberculosis during the Pandemic Period Journal of Clinical Medicine 12(14)
Bwana, V.; Tenu, F.; Magesa, S.M.; Mfinanga, S.G. 2011: Smear positive pulmonary tuberculosis among HIV patients receiving highly active antiretroviral therapy in Dar es Salaam, Tanzania Tanzania Journal of Health Research 13(1): 14-20
Hengel, R.L.; Allende, M.C.; Dewar, R.L.; Metcalf, J.A.; Mican, J.M.; Lane, H.C. 2002: Increasing CD4+ T cells specific for tuberculosis correlate with improved clinical immunity after highly active antiretroviral therapy Aids Research and Human Retroviruses 18(13): 969-975
Zielniewicz, B.; Klimczyk, M.; Chodera, B. 1971: Preliminary report on out-patient intermittent drug therapy in cases of active sputum-positive pulmonary tuberculosis Gruzlica i Choroby Pluc; Tuberculosis et Pneumonologia 39(7): 668-670
Girardi, E.; Sabin, C.A.; d'Arminio Monforte, A.; Hogg, B.; Phillips, A.N.; Gill, M.John.; Dabis, F.; Reiss, P.; Kirk, O.; Bernasconi, E.; Grabar, S.; Justice, A.; Staszewski, S.; Fätkenheuer, G.; Sterne, J.A.C. 2005: Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41(12): 1772-1782
Schulte-Holtey, H.F. 1983: The active plate in changing times Zwr 92(12): 50-56; 59
Waisman, J.L.; Palmero, D.J.; Alberti, F.A.; Güemes Gurtubay, J.L.; Francos, J.L.; Negroni, R. 2001: Improved prognosis in HIV/AIDS related multi-drug resistant tuberculosis patients treated with highly active antiretroviral therapy Medicina 61(6): 810-814
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Rudoĭ, N.M.; Zelenskaia, A.B.; Erkovskaia, O.I. 1975: Treatment of sputum and other pathological material with surface-active agents for isolation of Mycobacteria tuberculosis Laboratornoe Delo 8: 487-489
Pregowski, W. 1981: Results of a survey conducted in various Polish centers on the treatment effectiveness in active tuberculosis and drug resistance Pneumonologia Polska 49(7): 521-525
Lozovskaia, M.E. 2005: Effectiveness of using the biologically active additive to food from Laminaria in adolescents during complex treatment of the pulmonary tuberculosis Voprosy Pitaniia 74(1): 40-43
Balcha, T.T.; Skogmar, S.; Sturegård, E.; Björkman, P.; Winqvist, N. 2015: Outcome of tuberculosis treatment in HIV-positive adults diagnosed through active versus passive case-finding Global Health Action 8: 27048
Ravimohan, S.; Tamuhla, N.; Steenhoff, A.P.; Letlhogile, R.; Makutu, D.K.; Nfanyana, K.; Rantleru, T.; Tierney, A.; Nkakana, K.; Schwartz, A.B.; Gross, R.; Macgregor, R.R.; Bellamy, S.L.; Frank, I.; Weissman, D.; Bisson, G.P. 2013: Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis Journal of Infectious Diseases 208(11): 1784-1793